60 related articles for article (PubMed ID: 838852)
1. Failure of papaverine to alter L-dopa-influenced GH and PRL secretion.
Cooper DS; Jacobs LS
J Clin Endocrinol Metab; 1977 Mar; 44(3):585-7. PubMed ID: 838852
[TBL] [Abstract][Full Text] [Related]
2. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
[TBL] [Abstract][Full Text] [Related]
3. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
Fine SA; Frohman LA
J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
[TBL] [Abstract][Full Text] [Related]
4. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
5. The effects of l-DOPA and sulpiride on growth hormone secretion at different injection times in Holstein steers.
Kasuya E; Sutoh M; Yayou KI
Anim Sci J; 2017 Nov; 88(11):1842-1848. PubMed ID: 28585780
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone and prolactin release in acromegalic patients following metergoline administration.
Delitala G; Masala A; Alagna S; Devilla L; Lotti G
J Clin Endocrinol Metab; 1976 Dec; 43(6):1382-6. PubMed ID: 1002821
[TBL] [Abstract][Full Text] [Related]
7. Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man.
Woolf PD; Lantigua R; Lee LA
J Clin Endocrinol Metab; 1979 Sep; 49(3):326-30. PubMed ID: 468965
[No Abstract] [Full Text] [Related]
8. Inhibitory effect of cimetidine on L-dopa-stimulated growth hormone release in normal man.
Zanoboni A; Galmozzi G; Marinoni S; Zanoboni-Muciaccia W
Clin Endocrinol (Oxf); 1984 Nov; 21(5):535-40. PubMed ID: 6499233
[TBL] [Abstract][Full Text] [Related]
9. Pooled prolactin measurements in the evaluation of short children.
Shulman DI; Hu CS; Root AW; Bercu BB
J Clin Endocrinol Metab; 1989 Dec; 69(6):1261-7. PubMed ID: 2511222
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of growth hormone and prolactin response to levodopa during pyridoxine administration.
Delitala G; Masala A
Biomedicine; 1977 Jul; 27(6):219-22. PubMed ID: 20170
[TBL] [Abstract][Full Text] [Related]
11. The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.
Leblanc H; Yen SS
Am J Obstet Gynecol; 1976 Sep; 126(2):162-4. PubMed ID: 961756
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
13. [Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome].
Wu X; Gu Q; Su Y
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):489-91. PubMed ID: 9639745
[TBL] [Abstract][Full Text] [Related]
14. L-dopa absorption and the pituitary-hypothalamic axis.
Boyd AE; Angoff G; Long A; Mager M
J Clin Endocrinol Metab; 1978 Dec; 47(6):1341-7. PubMed ID: 263355
[TBL] [Abstract][Full Text] [Related]
15. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
Mims RB; Scott CL; Modebe O; Bethune JE
J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic regulation of growth hormone (GH) secretion in normal man: correlation of L-dopa and dopamine levels with the GH response.
Bansal S; Lee LA; Woolf PD
J Clin Endocrinol Metab; 1981 Aug; 53(2):301-6. PubMed ID: 7251816
[No Abstract] [Full Text] [Related]
18. Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease.
Bell RD; Carruth A; Rosenberg RN; Boyar RM
J Clin Endocrinol Metab; 1978 Oct; 47(4):807-11. PubMed ID: 45469
[TBL] [Abstract][Full Text] [Related]
19. Effect of experimentally induced hyperprolactinemia on growth hormone secretion.
Esquifino AI; Fernández-Ruiz JJ; Cebeira M; Agrasal C; Tresguerres JA; Ramos JA
Rev Esp Fisiol; 1987 Dec; 43(4):463-8. PubMed ID: 3448711
[TBL] [Abstract][Full Text] [Related]
20. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
Atkin SL; Landolt AM; Jeffreys RV; Diver M; Radcliffe J; White MC
J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
